Millennium Management’s GSK GSK Stock Holding History

Millennium Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6M	Buy	+191,900	New	+$10.4M	﹤0.01%	2118
2025 Q3	–	Sell	-473,100	Closed	-$18.2M	–	6189
2025 Q2	$18.2M	Buy	473,100 +122,600	+35%	+$4.68M	0.01%	1674
2025 Q1	$13.6M	Buy	350,500 +288,800	+468%	+$10.6M	0.01%	1886
2024 Q4	$2.09M	Sell	61,700 -546,400	-90%	-$19.7M	﹤0.01%	3612
2024 Q3	$24.9M	Sell	608,100 -143,000	-19%	-$5.85M	0.01%	1353
2024 Q2	$28.9M	Buy	751,100 +590,000	+366%	+$24.8M	0.01%	1182
2024 Q1	$6.91M	Buy	161,100 +124,400	+339%	+$5.13M	﹤0.01%	2535
2023 Q4	$1.36M	Buy	36,700 +3,400	+10%	+$122K	﹤0.01%	3921
2023 Q3	$1.21M	Buy	+33,300	New	+$1.18M	﹤0.01%	4033
2023 Q2	–	Sell	-30,000	Closed	-$1.07M	–	6336
2023 Q1	$1.07M	Buy	+30,000	New	+$1.05M	﹤0.01%	4031
2022 Q2	–	Sell	-400,000	Closed	-$21.8M	–	7170
2022 Q1	$21.8M	Buy	+400,000	New	+$21.7M	0.01%	1308
2021 Q2	–	Sell	-40,000	Closed	-$1.78M	–	6733
2021 Q1	$1.78M	Buy	+40,000	New	+$1.82M	﹤0.01%	3644
2020 Q3	–	Sell	-5,600	Closed	-$286K	–	4595
2020 Q2	$286K	Hold	5,600	–	–	﹤0.01%	3681
2020 Q1	$265K	Sell	5,600 -24,000	-81%	-$1.28M	﹤0.01%	3248
2019 Q4	$1.74M	Buy	+29,600	New	+$1.65M	﹤0.01%	2699
2014 Q3	–	Sell	-5,600	Closed	-$374K	–	3804
2014 Q2	$374K	Buy	+5,600	New	+$379K	﹤0.01%	2754
2013 Q4	–	Sell	-102,400	Closed	-$6.42M	–	3563
2013 Q3	$6.42M	Buy	+102,400	New	+$6.59M	0.02%	968

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Millennium Management's GSK Position: Q1 2026 in Review

Millennium Management reduced its GSK (GSK) stake by 91% in Q1 2026, selling an estimated $2.14M and leaving 4,067 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #5133.

Millennium Management first reported a position in GSK in Q3 2013 and has held it in 49 quarters since. The position peaked at $156M in Q4 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Millennium Management held 4,067 shares of GSK worth $224K as of Q1 2026.
Millennium Management sold 39,538 GSK shares in Q1 2026, an estimated $2.14M.
GSK made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5133 holding.
Millennium Management first reported a position in GSK in Q3 2013 and has held it in 49 quarters since.
Millennium Management's GSK position peaked at $156M in Q4 2022.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.